Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
GLP-1 drugs used for weight loss involve all kinds of side effects—good and not-so-good—that may or may not strike the ...
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
45m
The Centers for Medicare & Medicaid Services (CMS) said Friday that it had selected another 15 drugs for its second round of ...
The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...
Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health ...
The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback